In litigation to establish inventorship of the CRISPR gene editing technique, the Fed. Circuit provided additional guidance on how to determine when conception of an invention has occurred.
Read more at: https://www.law360.com/ip/articles/2338726?nl_pk=95cd90ef-6b5f-45a4-a80b-037d2c8892f4&utm_source=newsletter&utm_medium=email&utm_campaign=ip&utm_content=2025-05-13&read_more=1&nlsidx=0&nlaidx=0?copied=1
“The appropriate analysis should turn on whether [CVC’s] scientists ‘had formed the idea of their use for that purpose in sufficiently final form that only the exercise of ordinary skill remained to reduce it to practice’ — more than a ‘general hope,’ but less than knowing with certainty that the invention would work.”
Author(s)
Related Insights
July 6, 2026
Foley Viewpoints
QSBS Trust Stacking Comes Under the Microscope
First enacted in 1993, Qualified Small Business Stock (QSBS) has been one of the most powerful wealth-building tools for founders, early employees, and venture investors. Section 1202 of the Internal Revenue Code allows up to $15 million in capital gains to be shielded from federal taxes on the sale of qualifying stock, provided the stock is held long enough and the company meets the statutory requirements. That benefit became even more valuable after Congress expanded the exclusion in 2025.
July 6, 2026
Foley Viewpoints
Oregon EPR Producers May Have an Off-Ramp From Paying CAA, At Least Temporarily
Thousands of producers currently writing checks to Circular Action Alliance (CAA) under Oregon's Extended Producer Responsibility (EPR)…
July 2, 2026
Foley Viewpoints
NIH’s “All of Us” Milestone: Closing the Data Gap in AI Drug Repurposing
On June 30, 2026, the National Institutes of Health announced that its All of Us Research Program has become the world's largest…